Historial de carrera de Rob Ortmann
Antiguos cargos conocidos de Rob Ortmann.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Director Técnico/Científico/I+D | 01/05/2021 | 01/05/2022 |
| ASTRAZENECA PLC | Corporate Officer/Principal | - | - |
Formación de Rob Ortmann.
| Case Western Reserve University School of Medicine | Doctorate Degree |
Estadísticas
Internacional
| Irlanda | 2 |
| Reino Unido | 2 |
| Estados Unidos | 2 |
Operativa
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| Empresas privadas | 1 |
|---|---|
Horizon Therapeutics Plc
 Horizon Therapeutics Plc Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland. | Health Technology |
- Bolsa de valores
- Insiders
- Rob Ortmann
- Experiencia
